#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Germ cell cancer Congenital absence of bile ducts Synovial sarcoma recurrent PIK3CA-activated mutation Anti-myelin-associated glycoprotein associated polyneuropathy Hyperoxaluria Myelofibrosis Biotinidase deficiency Osteosarcoma recurrent Osteosarcoma B-cell lymphoma Pleomorphic liposarcoma Meningitis meningococcal Medullary thyroid cancer Chronic inflammatory demyelinating polyradiculoneuropathy More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Trials in Disease Pleomorphic leiomyosarcoma – Trials in Disease Haemophilia B with anti factor IX – Basic Information Rhabdoid tumour – Treatment Glomerulonephritis membranoproliferative – Basic Information Aicardi-Goutieres syndrome – Diagnostics VEXAS syndrome – Diagnostics Idiopathic pulmonary fibrosis – Treatment Leiomyosarcoma recurrent – Life with Disease Prolymphocytic leukaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tolvaptan Linsitinib TTX-381 Thiamine Hydrochloride Tilmanocept CAMOSTAT MESILATE Tasipimidine Nintedanib AGANIRSEN Ddcart‐Cd19 AMG 732 Venlafaxine Hydrochloride Maralixibat Chloride Prednisolone Acetate Emrusolmin ATTR-01 177LU-FAP-2286 Gemtuzumab Ozogamicin GSKVX000000070965 Amy109 More therapies…

    Learn about Your Condition

    Chronic disease Cholecystitis acute Peritonitis Primary hypercholesterolaemia B-cell lymphoma recurrent Hepatic neoplasm Renal transplant Glycogen storage disorder Urticaria chronic HER2 positive gastric cancer Urinary tract infection Mechanical ventilation Radiation skin injury Immune-mediated enterocolitis Bladder cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Abdominal infection
    • Bacterial infection
    • Infection
    Investigated Drugs:
    • Amikacin
    • Avibactam Sodium
    • Aztreonam
    Czechia Greece Hungary Spain

  • Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin Hydrochloride Monohydrate
    • Clindamycin
    • Levofloxacin
    The Netherlands

  • Study on the Effects of Rifampicin, Amoxicillin, and Moxifloxacin in Treating Prosthetic Joint Infections Caused by Cutibacterium acnes for Affected Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Clindamycin
    • Moxifloxacin
    • Rifampicin
    France

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mycobacterium abscessus infection
    Investigated Drugs:
    • Amikacin
    • Azithromycin
    • Bedaquiline
    Denmark

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain abscess
    Investigated Drugs:
    • Clindamycin
    • Linezolid
    • Meropenem Anhydrous
    Denmark France The Netherlands Sweden

  • Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cefalexin
    • Cefazolin
    France Germany The Netherlands Sweden
Previous Page
1 … 17 18 19 20 21 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!